Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2017	Mar. 31, 2017
Assets
Cash and cash equivalents	$ 30,462	$ 14,247
Accounts receivable, net of allowance for doubtful accounts of $4,600 and $4,084	124,408	128,544
Inventories, net	26,839	25,382
Costs/estimated earnings in excess of billings on uncompleted contracts	72,564	71,930
Assets held for sale	2,081	0
Other assets	30,952	28,544
Total current assets	287,306	268,647
Property, plant and equipment, net	25,064	29,103
Intangibles, net	63,084	68,820
Deferred tax asset	55,541	53,539
Other assets	8,224	7,008
Total assets	439,219	427,117
Liabilities
Accounts payable	71,412	69,858
Accrued compensation and benefits	17,379	21,576
Deferred revenue	28,316	31,624
Billings in excess of costs/estimated earnings on uncompleted contracts	13,637	16,536
Short-term debt	5,756	964
Other liabilities	35,350	36,955
Total current liabilities	171,850	177,513
Long-term debt	123,409	88,782
Other liabilities	16,835	19,173
Total liabilities	312,094	285,468
Stockholders’ equity
Preferred stock authorized 5,000, par value $1.00, none issued	0	0
Common stock authorized 100,000, par value $.001, 15,138 and 14,960 shares outstanding, 26,876 and 26,654 issued	26	26
Additional paid-in capital	509,688	506,449
Retained earnings	43,284	66,246
Accumulated other comprehensive income (loss)	(9,889)	(15,481)
Treasury stock, at cost 11,738 and 11,694 shares	(415,984)	(415,591)
Total stockholders’ equity	127,125	141,649
Total liabilities and stockholders’ equity	$ 439,219	$ 427,117